Association of Body Mass Index Changes during Neoadjuvant Chemotherapy with Pathologic Complete Response and Clinical Outcomes in Patients with Locally Advanced Breast Cancer

The purpose of this study was to determine the association between body mass index (BMI) measurements (baseline BMI and changes in BMI during neoadjuvant systemic treatment [NST]) and clinical efficacy (pathologic complete response [pCR] rate and survival outcomes) in locally advanced breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Kogawa, Takahiro, Fouad, Tamer M., Wei, Caimiao, Masuda, Hiroko, Kai, Kazuharu, Fujii, Takeo, El-Zein, Randa, Chavez-MacGregor, Mariana, Litton, Jennifer K., Brewster, Abenaa, Alvarez, Ricardo H., Hortobagyi, Gabriel N., Valero, Vicente, Theriault, Richard, Ueno, Naoto T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349870/
https://www.ncbi.nlm.nih.gov/pubmed/25767600
http://dx.doi.org/10.7150/jca.10580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349870/
https://www.ncbi.nlm.nih.gov/pubmed/25767600
http://dx.doi.org/10.7150/jca.10580

Ejemplares similares